Trials / Completed
CompletedNCT01732965
NB-UVB and PUVA Vitiligo Study
Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Phototherapy | |
| OTHER | Phototherapy and Photochemotherapy |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Completion
- 2014-05-01
- First posted
- 2012-11-26
- Last updated
- 2017-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01732965. Inclusion in this directory is not an endorsement.